-
Large-scale prospective research analysis shows that if you quit smoking, limit alcohol and eat more garlic, you will not have stomach cancer. You have the final say!
Time of Update: 2020-07-18
previous case-control studies based on Linqu population support that smoking rather than alcohol consumption is a risk factor for gastric cancer.
this large-scale prospective study analysis once again supports smoking as a risk factor for gastric cancer incidence and mortality.
-
JEM: Cracking the mystery of smoking promotes lung cancer cells to get into the brain! Scientists have found that nicotine can alter the properties of small glial cells, making the brain suitable for cancer cells to grow.
Time of Update: 2020-07-18
Picture from pexel.com Their experiments found that nicotine in cigarette smoke can cross the blood-brain barrier and reach the brain, prompting macrophages microglia in the brain to change their phenotypes, increase the secretion of growth promoting factors and chemokines, and promote the formation and development of metastatic foci.
-
China Guide Authoritative Voice - Donafini included in CSCO 'Primary Liver Cancer Diagnosis And Treatment Guide' to receive I-level expert recommendation.
Time of Update: 2020-07-18
it is reported that donafinil has been included and strongly recommended in this CSCO guideline for the diagnosis and treatment of primary liver cancer, which is based on the excellent results of the multicenter ll / ll phase clinical study (zgdh3 trial) of donafinil and sorafenib in the first-line treatment of advanced HCC published during the ASCO annual meeting recently.
-
This "pulmonary fibrosis and lung cancer" reading cheat, please put it away!
Time of Update: 2020-07-18
Today, let's learn about the series of CT reading films of pulmonary interstitial fibrosis combined with lung cancer ~ let's first look at a group of CT pictures (Fig. 1-3).
Fig. 13 of course, the diagnosis of pulmonary interstitial fibrosis + lung cancer still needs pathological drip.
-
The University of Southern California has teamed up with 10X Genomics to develop new single-cell technology that reveals the genetic diversity of cancer.
Time of Update: 2020-07-18
using a single cell sequencing method based on microdroplets, the researchers sequenced nearly 1500 single cell genomes at the same time, revealing the genetic diversity previously hidden in well studied melanoma cell lines.
-
10 plus tumor genome grouping on the new.
Time of Update: 2020-07-18
multi factor deep learning reveals that Pan cancer genomic tumor clusters have unique immune gene status and response to immunotherapy Abstract in this study, the authors developed a pan cancer deep machine learning model integrating tumor mutation load, microsatellite DNA instability and somatic cell copy number change.
-
Professor Wang Jie: China's first small cell lung cancer guide came out, the authority led the SCLC diagnosis and treatment.
Time of Update: 2020-07-18
initial treatment for patients with extensive stage SCLC without local symptoms and brain metastases: if PS score is 0-2 or 3-4 (due to SCLC), grade I recommends that etoposide + carboplatin + atilizumab is preferred after 4 cycles of sequential atilizumab maintenance therapy (type 1A evidence).
-
Immunotherapy re-introduced metastatic renal cell carcinoma, with an efficiency of 23%!
Time of Update: 2020-07-17
In the past five years, several immune checkpoint inhibitors (ICI) have been approved for the treatment of metastatic renal cell carcinoma (mRCC), including navulizumab alone or in combination with epilimumab, pabolizumab + acitinib, avelumab + acitinib.
-
2020 BOC/BOA. Annual progress in liver and bile pancreas research.
Time of Update: 2020-07-17
phase II apact study albumin paclitaxel combined with gemcitabine compared with gemcitabine monotherapy in adjuvant treatment of pancreatic cancer: prognosis in different regions.
-
First-line treatment for ovarian cancer! Roche Tecentriq s/Avastin-Chemotherapy Program Phase III Clinical: Failure to Extend Progressless Survival!
Time of Update: 2020-07-17
!--:pagetitle"--/ -- Roche has announced the latest advances in the anti-PD-L1 therapy Tecentriq (Tesanchi, generic name: atezolizumab, atlizumad) first-line treatment for newly diagnosed women with a
-
Self Renew column, F-627 of Efan Medicine.
Time of Update: 2020-07-17
according to the small edition, combined with the differentiation of f-627 and the average market share of biological similar drugs in the United States, the peak foreign sales of f-627 can be conservatively estimated at 1 / 10 of the peak sales of neulasta (about 4.7 billion US dollars), that is, about 500 million US dollars.
-
Transformil-18 enhances cancer immunotherapy.
Time of Update: 2020-07-17
Cytokine is a secreted protein that can be used in immunotherapy for tumors but because the specificity of its treatment is not ideal, and may be toxic, so clinical application is limited IL-18 is a
-
Whether the genetic risk is high or low, doing these points can reduce the risk of breast cancer.
Time of Update: 2020-07-17
source: to assess whether a healthy lifestyle can reduce the risk of breast cancer in people with different genetic risks, researchers from the University of Manchester in the UK Pixabay analyzed data from UK Biobank, the largest human genetic cohort sample bank in the world, involving more than 90 thousand female subjects over the age of 40.
-
2020 CSCO BC Conference . . . Fellow Wang Xiaodong: Innovation and Challenge of Biomedicine.
Time of Update: 2020-07-17
basic research and new drug creation: case study -- mechanism of apoptosis induced by estrogen: Academician Wang's research team first found that high concentration of estrogen can induce cell apoptosis in a dose-dependent manner.
-
Chinese scientists have revealed for the first time a panoramic view of the molecules of lung adenocarcinoma.
Time of Update: 2020-07-17
Lung cancer is the highest incidence rate and mortality rate in China and even worldwide. in China, there are more than 700000 lung cancer cases and more than 600000 deaths every year in China. lung a
-
230,000 studies confirmed the risk of serrated polyps raising the risk of colon cancer, and Professor Huang Xiaojun led the JCO article. Tumor intelligence.
Time of Update: 2020-07-17
Jto: guidelines for diagnosis and management of patients with pulmonary neuroendocrine tumors Chinese Journal of oncology: consensus of clinicopathologists on detection of PD-L1 expression in non-small cell lung cancer in China The journal updated the perspectives column online to report the results of a large retrospective study published on July 7 in gastroenterology, providing more accurate information on the relationship between serrated polyps (SP) and the risk of colon cancer.
-
Nature Sub-Journal: Drug screening combined with CRISPR technology to improve the efficacy of anti-cancer drugs.
Time of Update: 2020-07-17
this further understanding of the biological mechanisms supporting drug response will help us develop new cancer drugs more quickly and effectively, and bring us closer to the precise treatment of cancer patients.
-
The study found a new mechanism for reprogramming the metabolism of liver cancer.
Time of Update: 2020-07-17
Recently, the international academic journal Nature cancer published online the latest research results of Yin Huiyong, Shanghai Institute of nutrition and health, Chinese Academy of Sciences, which clarified the role, mechanism and clinical significance of fructose-1,6-diphosphate (FBP) aldolase B (aldob) in regulating metabolic reprogramming of liver cancer.
-
CD20xCD3 bispecific antibodies! Rochemosuuzumab is qualified by FDA for breakthrough drug treatment for follicular lymphoma (FL)
Time of Update: 2020-07-17
!--webeditor:page title"--July 14, 2020 /PRNewswire/ -- Roche has announced that the U.S Food and Drug Administration (FDA) has granted the Mosunetuzumab Breakthrough Drug (BTD), a T-cell-combined CD2
-
Sci Adv . . . Liu Bin/Liu Xiaogang/Kong De-ling co-developed a new nanoimmune stimulator to remove malignant solid tumors.
Time of Update: 2020-07-17
After nearly ten years of development, immunotherapy has become one of the most promising methods to cure cancer. however, in the process of immunotherapy, how to avoid excessive activation of immune
